SEC Form D · Amendment · filed April 16, 2021
Aro Biotherapeutics Co
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (33)
Mark B. Laurenzi · Philadelphia, PAExecSusan B. Dillon · Philadelphia, PAExec · DirectorSaan-Chirag B. Gandhi · Philadelphia, PADirectorKevin B. Raidy · Philadelphia, PADirectorElizabeth B. Anderson · Philadelphia, PADirectorScott B. Greenberg · Philadelphia, PAExecBruce B. Peacock · Philadelphia, PADirectorJess B. Lifton · Philadelphia, PADirectorKaryn B. O'Neil · Philadelphia, PAExec · DirectorMarten B. Steen · Philadelphia, PADirectorChristopher B. Mirabelli · Philadelphia, PADirectorSteven A. Przybyla · BUFFALO, NYDirectorMichael A. Zercher · BUFFALO, NYDirectorRoger D. O'Brien · BUFFALO, NYDirectorMatthew S. Thompson · Fort Collins, CODirectorClifford B. Fleet · BUFFALO, NYDirectorJamie S. Haggard · Fort Collins, COExec · DirectorJames A. Mish · BUFFALO, NYExecJohn A. Franzino · BUFFALO, NYDirectorCharles R. Conn · Oxford, United KingdomDirectorKevin C. Smith · Denver, COExec · DirectorSteve S. Deitsch · Fort Collins, COExecCraig Dickman · GREEN BAY, WIDirectorBob Vruggink · STEAMBOAT SPRINGS, COExecTyler Ellison · EGG HARBOR, WIExec · DirectorBill Butler · LOS ANGELES, CAExec · DirectorC. D. Adair · Nashville, TNDirectorHeidi Ridley · Orinda, CADirectorMaurcio Bustos · Orinda, CADirectorPatricia K. Salame · Oklahoma City, OKDirectorAlfredo Marti · Stamford, CTDirectorJoshua Goldberg · Baltimore, MDDirectorKenneth Ryan · Stamford, CTExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗